Literature DB >> 10918055

Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle.

Q Xu1, Y Li, C Cyras, D A Sanan, B Cordell.   

Abstract

Amyloid Abeta deposition is a neuropathologic hallmark of Alzheimer's disease. Activated microglia are intimately associated with plaques and appear to facilitate Abeta deposition, an event believed to contribute to pathogenesis. It is unclear if microglia can modulate pathogenesis of Alzheimer's disease by secreting lipoprotein particles. Here we show that cultured BV2 murine microglial cells, like astrocytes, secrete apolipoprotein E (apoE) and apolipoprotein J (apoJ) in a time-dependent manner. To isolate and identify BV2 microglial particles, gel filtration chromatography was employed to fractionate BV2-conditioned medium. Analyses by Western blot, lipid determination, electron microscopy, and native gel electrophoresis demonstrate that BV2 microglial cells release spherical low density lipoprotein (LDL)-like lipid-containing particles rich in apoJ but poor in apoE. These microglial particles are dissimilar in size, shape, and lipoprotein composition to astrocyte-derived particles. The microglial-derived particles were tested for functional activity. Under conditions of suppressed de novo cholesterol synthesis, the LDL-like particles effectively rescued primary rat cortical neurons from mevastatin-induced neurotoxicity. The particles were also shown to bind Abeta. We speculate that the LDL-like apoJ-rich apoE-poor microglial lipoproteins preferentially bind the lipoprotein receptor, recognizing apoJ, which is abundant in the choroid plexus, facilitating Abeta clearance from the brain. BV2 cells also secrete an apoE-rich lipid-poor species that binds Abeta. Consistent with the role of apoE in Abeta fibril formation and deposition, this microglial species may promote plaque formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918055     DOI: 10.1074/jbc.M002796200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain.

Authors:  J Husemann; S C Silverstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.

Authors:  Elizabeth E Spangenberg; Rafael J Lee; Allison R Najafi; Rachel A Rice; Monica R P Elmore; Mathew Blurton-Jones; Brian L West; Kim N Green
Journal:  Brain       Date:  2016-02-26       Impact factor: 13.501

Review 3.  Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.

Authors:  Robert W Mahley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-12       Impact factor: 8.311

4.  Melatonin Induces Akt Phosphorylation through Melatonin Receptor- and PI3K-Dependent Pathways in Primary Astrocytes.

Authors:  Pil-Jae Kong; Jong-Seon Byun; So-Young Lim; Jae-Jun Lee; Sung-Jun Hong; Kwang-Jun Kwon; Sung-Soo Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-04-30       Impact factor: 2.016

5.  Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.

Authors:  Florence F Roussotte; Boris A Gutman; Sarah K Madsen; John B Colby; Paul M Thompson
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

6.  Atlas of signaling for interpretation of microarray experiments.

Authors:  Ekaterina Kotelnikova; Natalia Ivanikova; Andrey Kalinin; Anton Yuryev; Nikolai Daraselia
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

7.  Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Authors:  David A Elliott; Glenda M Halliday; Brett Garner
Journal:  BMC Neurosci       Date:  2010-02-20       Impact factor: 3.288

Review 8.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 10.  Microglial malfunction: the third rail in the development of Alzheimer's disease.

Authors:  Siddhita D Mhatre; Connie A Tsai; Amanda J Rubin; Michelle L James; Katrin I Andreasson
Journal:  Trends Neurosci       Date:  2015-10       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.